Alpek (MEX:ALPEKA) Cyclically Adjusted PS Ratio: 0.15 (As of Jul. 12, 2026) — 38% Below Median


MEX:ALPEKA Alpek SA MEX:ALPEKA
61 GF Score
Price MXN12.59
GF Value MXN10.65
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Alpek Cyclically Adjusted PS Ratio?

Alpek MEX:ALPEKA -0.08% 61 Cyclically Adjusted PS Ratio is 0.15 as of Jul. 12, 2026, which is 38% below its 10-year median of 0.24. GuruFocus rates MEX:ALPEKA with a GF Score™ of 61/100 and a GF Value™ of MXN10.65 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 1,279 Chemicals companies, Alpek ranks better than 96.25% on this metric.

As of today (2026-07-12), Alpek's current share price is MXN12.59. Alpek's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was MXN84.63. Alpek's Cyclically Adjusted PS Ratio for today is 0.15.

The historical rank and industry rank for Alpek's Cyclically Adjusted PS Ratio or its related term are showing as below:

MEX:ALPEKA' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.1   Med: 0.24   Max: 0.45
Current: 0.15

During the past years, Alpek's highest Cyclically Adjusted PS Ratio was 0.45. The lowest was 0.10. And the median was 0.24.

MEX:ALPEKA's Cyclically Adjusted PS Ratio is ranked better than
96.25% of 1279 companies
in the Chemicals industry
Industry Median: 1.32 vs MEX:ALPEKA: 0.15

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Alpek's adjusted revenue per share data for the three months ended in Mar. 2026 was MXN14.274. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is MXN84.63 for the trailing ten years ended in Mar. 2026.

Shiller PE for Stocks: The True Measure of Stock Valuation


Alpek  (MEX:ALPEKA) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Alpek Cyclically Adjusted PS Ratio Related Terms


Alpek Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Alpek's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpek Cyclically Adjusted PS Ratio Chart

Alpek Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 0.41 0.17 0.16 0.11

Alpek Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.12 0.12 0.11 0.13

MEX:ALPEKA vs LIN, SHW, ECL: Cyclically Adjusted PS Ratio Comparison

For the Specialty Chemicals subindustry, Alpek's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpek Cyclically Adjusted PS Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Alpek's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Alpek's Cyclically Adjusted PS Ratio falls into.


MEX:ALPEKA
61GF Score
Alpek SA MEX:ALPEKA
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpek Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Alpek's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=12.59/84.63
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpek's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Alpek's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=14.274/166.0400*166.0400
=14.274

Current CPI (Mar. 2026) = 166.0400.

Alpek Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 10.553 101.905 17.195
201609 10.921 103.084 17.591
201612 11.082 105.002 17.524
201703 12.442 108.063 19.117
201706 11.466 108.339 17.573
201709 11.041 109.628 16.723
201712 11.814 112.114 17.496
201803 13.579 113.505 19.864
201806 16.128 113.373 23.620
201809 17.398 115.130 25.091
201812 16.408 117.530 23.180
201903 14.904 118.050 20.963
201906 14.837 117.848 20.904
201909 13.963 118.581 19.551
201912 12.835 120.854 17.634
202003 13.486 121.885 18.371
202006 12.996 121.777 17.720
202009 13.878 123.341 18.682
202012 13.587 124.661 18.097
202103 15.544 127.574 20.231
202106 17.556 128.936 22.608
202109 19.731 130.742 25.058
202112 21.188 133.830 26.288
202203 22.690 137.082 27.483
202206 26.741 139.233 31.890
202209 28.358 142.116 33.132
202212 22.965 144.291 26.426
202303 18.308 146.472 20.754
202306 17.242 146.272 19.572
202309 15.837 148.446 17.714
202312 14.187 151.017 15.598
202403 15.353 152.947 16.667
202406 15.682 153.551 16.958
202409 17.634 155.246 18.860
202412 60.200 157.378 63.513
202503 16.638 158.761 17.401
202506 15.606 160.180 16.177
202509 14.747 161.030 15.206
202512 13.332 163.190 13.565
202603 14.274 166.040 14.274

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

What does a Cyclically Adjusted PS Ratio of 0.15 mean?
Alpek (MEX:ALPEKA) has a Cyclically Adjusted PS Ratio of 0.15 as of Jul. 12, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Alpek and its competitors. This is 38% below median its historical median of 0.24. Over the past decade, Alpek's Cyclically Adjusted PS Ratio has ranged from 0.10 to 0.45. According to the industry distribution chart, Alpek ranks #48 out of 1279 companies in the Chemicals industry, placing it in the top 3.8%.
Is Alpek's Cyclically Adjusted PS Ratio too high?
Alpek's current Cyclically Adjusted PS Ratio of 0.15 is 38% below median its 10-year median of 0.24. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 0.45. The Chemicals industry median Cyclically Adjusted PS Ratio is 1.32. Alpek's value of 0.15 is 88.6% below this industry median. Based on the distribution chart, Alpek ranks #48 out of 1279 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Alpek has a GF Score™ of 61/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alpek's Cyclically Adjusted PS Ratio compare to LIN and SHW?
According to the Chemicals industry distribution chart, Alpek ranks #48 out of 1279 companies for Cyclically Adjusted PS Ratio. This places Alpek in the top 4% of its industry — outperforming the majority of peers. The industry median Cyclically Adjusted PS Ratio is 1.32. Alpek's value of 0.15 is 88.6% below this benchmark. Historically, Alpek's own Cyclically Adjusted PS Ratio has ranged from 0.10 to 0.45 over the past decade. While the company's 10-year median is 0.24 vs. the industry median of 1.32, Alpek has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Chemicals company?
The median Cyclically Adjusted PS Ratio among Chemicals companies is 1.32, based on 1,279 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alpek's current Cyclically Adjusted PS Ratio of 0.15 is 88.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Alpek and its competitors. For the Chemicals industry, the median Cyclically Adjusted PS Ratio is 1.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpek's current Cyclically Adjusted PS Ratio is 0.15, which is 38% below median its own 10-year median of 0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpek stock overvalued right now?
Based on GuruFocus' analysis, Alpek (MEX:ALPEKA) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN10.65, compared to a current price of MXN12.59 — trading 18.2% above its estimated fair value. The current Cyclically Adjusted PS Ratio is 0.15, which is 38% below median its 10-year median of 0.24 and 88.6% below the Chemicals industry median of 1.32. Alpek's overall GF Score™ is 61/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For Alpek (MEX:ALPEKA), the current Cyclically Adjusted PS Ratio is 0.15 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alpek (MEX:ALPEKA) Overvalued in 2026?

Based on GuruFocus' analysis, Alpek stock appears to be overvalued. The current stock price of MXN12.59 is trading 18.2% above its estimated GF Value™ of MXN10.65. GuruFocus considers Alpek to be Modestly Overvalued.

Key valuation signals for MEX:ALPEKA:

  • Cyclically Adjusted PS Ratio: 0.15 (38% below median its 10-year median of 0.24)
  • GF Value™: MXN10.65 vs. price of MXN12.59 (18.2% above fair value)
  • GF Score™: 61/100 with 8 warning signs
  • Industry Position: 88.6% below the Chemicals median (#48 of 1279)

No single metric tells the full story. See the MEX:ALPEKA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alpek Business Description

Other Exchanges ALPKF:USA27A:Germany
Address Avenida Gomez Morin Sur No. 1111, Col. Carrizalejo, San Pedro Garza Garcia, NL, MEX, 66254
Alpek SA is a petrochemical company with operations through two business segments: Polyester and Plastic and Chemicals. The Polyester segment comprises the production of purified terephthalic acid (PTA), polyethylene terephthalate (PET), recycled PET (rPET), and polyester fibers, which are mainly used for food and beverage packaging, textile and industrial filament markets, and The Plastics & Chemicals business segment comprises the production of polypropylene (PP), expandable styrene (EPS and Arcel), fertilizers and other chemicals, which serves a wide range of markets, including the consumer goods, automotive, construction, agriculture, pharmaceutical, and other markets. The company derives a majority of its revenue from the polyester segment.
61GF Score

Get the complete analysis for MEX:ALPEKA

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN12.59
Price
MXN10.65
GF Value